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Abstract 
BACKGROUND: Cryptosporidium sp. is an apicomplexan protozoa, and it is related to an immunocompromised 
state. As it develops diverse clinical manifestations, mild to life-threatening conditions, administration of anti-
parasitic medication and its management remain problematic. 
AIM: The study aimed to provide Cryptosporidiosis symptomatology and its prevalence among HIV-infected 
patients in a tertiary referral hospital, Haji Adam Malik General Hospital, Medan, Indonesia. 
MATERIAL AND METHODS: Symptomatology was noted using short-questionnaire, and laboratory findings were 
obtained from the hospital medical record registry on the same day of admission. We enrolled 24 patients were 
suffered from HIV infection for a certain period and more than one-week diarrhoea including 18 males and 6 
females. Routine faeces examination using wet mount, Kinyoun-gabet, and trichrome staining was performed for 
all samples in Parasitology Department, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia. 
Numerical data were evaluated using the Mann-Whitney test while Fisher Exact test was used to determine any 
association between categorical variables. 
RESULTS: Our study found that 8 of 24 patients were positive with Cryptosporidium sp. while its symptomatology 
including abdominal cramp (66.7%), nausea and vomiting (70.8%), and fever (62.5%) is prevalent from our study. 
We obtained significant association between CD4 cell count (p = 0.006), diarrhea duration (p = 0.007), abdominal 
pain (p = 0.005), and nausea and vomiting (p = 0.021) with cryptosporidiosis. 
CONCLUSION: High consideration of several symptoms related to cryptosporidiosis leads a clinician to initiate 
prompt management particularly in a high-risk population. 
 
 
 
 
 
 
 
Introduction 
 
Cryptosporidium sp. first appearance was 
noted in 1976 when the organism infected a three-
year-old child with self-limiting enterocolitis while in 
early 1980s Cryptosporidium sp. had been linked to 
the immunocompromised population [1]. 
Cryptosporidium hominis and Cryptosporidium 
parvum are commonly associated with human 
infection. Ingestion of fully and chlorine resistant 
sporulated oocyst also initiate the infection in human. 
After the oocyst ingestion, upper small bowel will 
become the milieu for infection, and it develops into 
the further stage, as the sporozoite penetrates the 
enterocyte and transforms into the mature form [2]. 
The global burden for cryptosporidiosis was noted 
from several reports in Africa and Asia, 11.3% in 
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Turkey [3], 6% in Iran [4], and the highest prevalence 
found in Uganda as much as 73.6% [5]. Indonesia 
data prevalence of the infection is available based on 
two studies ranging from 4.9-52.5% [6], [7]. Most 
studies revealed that the prevalence variation of 
Cryptosporidium sp. among HIV-infected population 
occurred since the limitation of using proper 
diagnostic method particularly in developing regions is 
established [8]. 
The infection could produce broad clinical 
manifestations ranging from mild to life-threatening 
symptoms depends on the presence of comorbidities 
particularly HIV/AIDS status, malignancy, patients 
undergoing dialysis, and organ transplantation [9]. 
Cryptosporidium sp. as the most common species 
found in the HIV population and it is linked to higher 
mortality among population. Diarrhoea associated with 
cryptosporidiosis is watery or mucoid diarrhoea that 
persists ranging from acute to chronic form which 
caused several clinical implications to the patients 
including severe dehydration, abdominal pain, nausea 
and vomiting, fever, malnutrition, and significant 
weight loss [10]. Medication for cryptosporidiosis still 
becomes a problematic issue as its effectivity among 
the certain population is questionable while U.S Food 
and Drug Administration (FDA) only approved 
nitazoxanide which does not effectively eradicate the 
organism in immunocompromised hosts [11]. 
There has been no study related to 
symptomatology and cryptosporidiosis in Indonesia 
recently. Our study aimed to provide the prevalence of 
cryptosporidiosis among the HIV population and its 
symptomatology in a single institution, tertiary referral 
centre. Assessment and evaluation may be used to 
determine the likelihood that patients with certain 
symptomatology have Cryptosporidium sp. infection. 
 
 
Methods 
 
Study location and population 
We enrolled in a cross-sectional study 
conducted in one tertiary referral centre, Haji Adam 
Malik General Hospital, Medan, Indonesia. The study 
included 18 males and 6 females who had met the 
inclusion criteria, for instance: HIV positive patients, 
suffered from more than one-week diarrhoea and 
admitted to the outpatient clinic or hospitalisation 
ward. WHO defines diarrhoea as three or more loose 
stool per day for 72 hours (acute for no more than 13 
days; chronic or persistent diarrhoea is defined as 
diarrhoea for 14 days or more). Medical record 
registry was assessed to fulfil several variables 
related to demographic data (gender and age), and 
laboratory results including CD4+ cell count, 
haemoglobin, hematocrit, leukocyte, thrombocyte, 
urea, creatinine, and glucose levels. The laboratory 
results were obtained from Haji Adam Malik medical 
record registry on the same day of their admission to 
the hospital. A short questionnaire was also used to 
determine symptomatology of all participants 
consisting of three-panel question about the presence 
of abdominal pain, nausea and vomiting, and fever; 
the physical examination was performed to ascertain 
the symptomatology. 
 
Parasitological examination 
All participants had given their approval to 
include in the study. On the day of admission, a small 
faecal sample container was given to the patients. On 
the following day, sample collection was performed by 
our laboratory staff; no preservation was applied to 
samples. In the same day of sample collection, the 
microscopic examination was carried out in the 
Parasitology Department, Faculty of Medicine, 
Universitas Sumatera Utara, Medan, Indonesia. A 
battery of examination was conducted to determine 
the presence of Cryptosporidium sp., and other 
pathogenic parasites including routine faeces 
examination using wet mount, Kinyoun-gabet, and 
trichrome staining. As a matter of limitation in the 
study, bacterial culture and viral marker examination 
were not screened. The study had been evaluated by 
Health Research Ethical Committee of Faculty of 
Medicine, Universitas Sumatera Utara and obtained 
their approval. 
 
Statistics and study approval 
The research form and questionnaire were 
collected then transformed into one table in Microsoft 
Excel. Statistical Package for Social Sciences 21 
(SPSS Inc. version 21) in univariate fashioned using 
Fisher Exact test was used to determine any 
significant presence relationship between several 
variables and Cryptosporidiosis. Furthermore, numeric 
data were evaluated using the non-parametric Mann-
Whitney test to evaluate the mean difference between 
positive and negative groups of cryptosporidiosis 
including age, CD4+ cell count, diarrhoea duration 
and several laboratory results. 
 
 
Results 
 
We proved that 8 of 24 patients were positive 
for Cryptosporidium sp. and one patient was positive 
with double infection, Cryptosporidium sp. and 
Blastocystis hominis. The demographic data were 
depicted in Table 1. One-week diarrhoea was 
commonly found in our study while there was one 
patient who had suffered from 24-week-diarrhoea. 
Symptomatology among patients was also assessed; 
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it revealed that abdominal pain (66.7%), nausea and 
vomiting (70.8%), and fever (62.5%) were prevalent 
among participants. Laboratory results baseline also 
listed in Table 1. 
The symptomatology including abdominal 
pain, nausea and vomiting, and fever was evaluated 
using short questionnaire while abdominal pain and 
nausea and vomiting had a significant association with 
the infection, p = 0.005 PR 21.00 95% CI 2.372-
185.93 and p = 0.021 PR 0.086 95% CI 0.011-0.673 
respectively. Abdominal pain was complained by 6 of 
8 cryptosporidiosis patients. Nevertheless, we proved 
descriptively that most of the patients who complained 
about nausea and vomiting were demonstrated as 
negative for Cryptosporidium sp. Several variables, 
then, was also statistically evaluated using Mann-
Whitney testing since the data was not normally 
distributed. We obtained significant association 
between CD4+ cell count (p = 0.006), diarrhea 
duration (p = 0.007), and leukocyte (p = 0.038) with 
cryptosporidiosis. 
Table 1: Several variables among cryptosporidiosis patients 
Characteristics Cryptosporidiosis (Mean ± SD) p-value 
Positive (8/33.3%) Negative (16/66.7%) 
Age (year) 36.50 ± 7.28 42.93 ± 12.10 0.238 
Gender (Male/Female) 5/3 13/3 0.621 
CD4+ cell count (/µL) 87.37 ± 141.16 319.50 ± 160.39 0.006* 
Diarrhea duration (weeks) 7.25 ± 7.34 1.81 ± 1.10 0.007* 
Laboratory results 
Hemoglobin (gr/dL) 
Thrombocyte (cell/ µL) 
Hematokrit (%) 
Leukocyte (cell/µL) 
Glucose levels (mg/dL) 
Creatinin (mg/dL) 
Ureum (mg/dL) 
 
8.98 ± 1.42 
195,250.00 ± 81,32 
37.10 ± 11.83 
6,428.75 ± 2,475.04 
86.12 ± 15.19 
0.88 ± 0.60 
32.40 ± 21.51 
 
10.64 ± 1.88 
229,537.50 ± 117,216.30 
35.37 ± 7.09 
9,238.12 ± 3,220.81 
117.18 ± 76.95 
2.04 ± 2.33 
68.49 ± 73.15 
 
0.070 
0.490 
0.834 
0.038* 
0.320 
0.291 
0.320 
Symptomatology (Yes/No) 
Abdominal pain 
Nausea and vomiting 
Fever 
 
6/2 
3/5 
5/3 
 
2/14 
14/2 
10/6 
 
0.005* 
0.021* 
1.000 
*, statistically significant. 
 
 
 
Discussion 
 
As part of the neglected tropical disease, 
cryptosporidiosis still becomes problematic since it 
can produce several symptoms ranging from mild, 
self-limiting disease to severe dehydration or death 
[12]. Also, Cryptosporidium sp. is categorised as a 
highly infectious organism, infectious dose until it can 
initiate infection as low as 10 oocysts [13]. 
Immunocompromised status particularly HIV/AIDS 
infection also had been linked to the infection and its 
presence become a leading causative agent can 
produce the debilitating condition among the 
population. Inadequacy of the diagnostic method of 
Cryptosporidium sp. also challenges the findings of 
the organism [14]. 
Immunologic response of Cryptosporidium sp. 
invasion is emphasised from literature, the elevation 
of certain cytokines such as interferon-gamma (IFN-
ϒ), interleukin-1β (IL-1β), tumour necrosis factor-
alpha (TNF-α), interleukin-10 (IL-10) and transforming 
growth factor-β (TGF- β), is evident [15]. Intestinal 
epithelial cells (IECs) detect Cryptosporidium sp. and 
initiate the recognition of the organism to CD4+ cell 
via Major Histocompatibility Complex-II (MHC-II) [16]. 
As HIV destruct CD4+ cell, cell-mediated immunity 
arm among HIV-infected individuals will severely 
impair resulting in ineffective eradication of the 
organisms [17], [18]. Our study proved a significant 
difference in CD4+ cell count between two groups of 
patients, infected- and uninfected-group (p = 0.006). 
Cryptosporidiosis group had CD4+ cell count which 
was significantly lower than the negative group. 
Furthermore, the likelihood of getting the infection 
increases after CD4+ cell count falls to 50 cell/mm3 
[19], [20]. 
Morphologic changes including loss of 
microvilli resulting in disruption of several enzymes 
involved in the digestion process are crucial for 
developing symptoms among infected-individual [21]. 
Cryptosporidiosis patients mostly complained of 
watery diarrhoea, abdominal pain, anorexia, 
flatulence, nausea and vomiting, and mild fever. 
Significant association was obtained from our study 
particularly abdominal pain was related to 
cryptosporidiosis (p = 0.005) while nausea and 
vomiting was significantly associated with 
cryptosporidiosis in inversion manner (p = 0.021) 
since our study showed most patients complained the 
symptoms were negative for Cryptosporidium sp. 
(infected-patients complained nausea and vomiting 
versus uninfected-patients; 37.5% versus 87.5%). 
There are few published articles linked 
Cryptosporidium sp. with the presence of certain 
symptoms among the HIV population in Indonesia. 
Notwithstanding, several studies revealed the 
prevalence and symptoms produced during the 
infection, for instance, Wanyiri et al., [22] conducted a 
study in Kenya found 56 of 164 (34%) of HIV/AIDS 
patients were positive for Cryptosporidium sp. A 
significant association between abdominal pain and 
vomiting was also evident in the study. In Iran, Izadi et 
al., [23] also revealed similar results that two common 
symptomatology commonly found in cryptosporidiosis 
patients including abdominal pain and nausea and 
vomiting had a significant association with the 
infection.  
Association between chronicity and 
cryptosporidiosis among the HIV population stated 
from the literature [24], [25]. While our study obtained 
a significant difference between two groups, the mean 
of diarrhoea duration among infected group versus 
uninfected group was 7.25 versus 1.81 (p = 0.007). 
The condition may be clearly explained since the 
mainstay of therapy among HIV/AIDS population is 
the restoration of immune function. Immune 
reconstitution shortly occurred after effective 
administration of combination antiretroviral therapy 
has been associated with parasitic clearance. 
Duration of symptoms especially diarrhoea is directly 
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linked to the immune response in each [26]. 
Also, symptomatic management including 
replacement of fluids and electrolytes is essential to 
prevent further complications. Furthermore, 
administration of any anti-parasitic medication 
remains debatable [27]. 
In conclusion, the study has revealed several 
significant results by using a smaller sample size, yet 
it becomes the limitation of the study. Also, the 
evidence also has brought several clinical 
significances among cryptosporidiosis patients and 
the symptomatology. Therefore, the combination of 
HIV/AIDS positive status, diarrhoea, and abdominal 
pain increase the likelihood of a patient having the 
infection. The infection remains neglected not only in 
the general population but also among HIV/AIDS 
patients. The physician should increase awareness of 
the infection among HIV/AIDS patients since the 
infection and diarrhoea shown to be an independent 
predictor of mortality in the population. 
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